Ibutilide for treatment of atrial fibrillation in the emergency department
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationEmerg Med J 2006, 23(2):133-4
AbstractThe purpose of this study was to assess the efficacy and safety of ibutilide, a class III antiarrhythmic drug, for acute treatment of atrial fibrillation (AF) in the emergency department (ED) setting. A retrospective analysis was done reviewing all patients with AF who received ibutilide in the ED in a university hospital setting. A total of 22 patients received ibutilide. Another 24 patients who received rate control drugs only served as a control group. Of the 22 patients who received ibutilide, 14 (64%) converted to sinus rhythm. The mean (SD) rate of AF was 137 (24) bpm and the mean QTc interval immediately after conversion to sinus rhythm was 420 (28) ms. There were no complications. In the rate control group 7 patients (29%) converted to sinus rhythm (p<0.05, compared with ibutilide). The mean rate of AF was 126 (26) bpm (p = ns, compared with ibutilide) and the mean QTc interval in those who converted was 377 (28) ms (p<0.05, compared with ibutilide). One patient developed severe bradycardia. Ibutilide is effective for conversion of recent onset AF in patients presenting to the ED and there is a low rate of complications from ibutilide in this setting.
DescriptionTo access publisher version of this article. Please click on the hyperlink in Additional Links Field
To access full text version of this article. Please click on the hyperlink "View/Open" at the bottom of this page
- Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
- Authors: Mountantonakis SE, Moutzouris DA, Tiu RV, Papaioannou GN, McPherson CA
- Issue date: 2006 Jul
- Conversion of recent-onset atrial fibrillation or flutter with amiodarone after ibutilide has failed: a rapid, efficient, and safe algorithm.
- Authors: Dilaveris P, Synetos A, Giannopoulos G, Gialafos E, Stefanadis C
- Issue date: 2005 Jul
- Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.
- Authors: Vos MA, Golitsyn SR, Stangl K, Ruda MY, Van Wijk LV, Harry JD, Perry KT, Touboul P, Steinbeck G, Wellens HJ
- Issue date: 1998 Jun
- Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study.
- Authors: Bernard EO, Schmid ER, Schmidlin D, Scharf C, Candinas R, Germann R
- Issue date: 2003 Apr
- Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.
- Authors: Volgman AS, Carberry PA, Stambler B, Lewis WR, Dunn GH, Perry KT, Vanderlugt JT, Kowey PR
- Issue date: 1998 May